Table 1.
Descriptive Characteristics at Initiation of Antiretroviral Therapy by Race/Ethnicity
| Parameter | White ( = 3,106) | Black ( = 919) | Hispanic ( = 661) | a |
|---|---|---|---|---|
| Median years follow-up (IQR) | 4.7 (1.7, 8.0) | 3.4 (1.4, 6.6) | 3.5 (1.4, 6.6) | <0.001 |
| Male, % | 93.2 | 76.4 | 90.5 | <0.001 |
| Median age, years (IQR) | 42 (36, 49) | 41 (35, 48) | 37 (33, 44) | <0.001 |
| Median year ART initiation (IQR) | 1998 (96, 01) | 1999 (97, 02) | 1999 (97, 02) | <0.001 |
| HIV risk factor, % | <0.001 | |||
| Men who have sex with men | 70.7 | 41.2 | 61.6 | |
| Injection drug use | 7.0 | 9.0 | 5.8 | |
| Heterosexual sex | 9.7 | 32.4 | 19.5 | |
| Other/Unknown | 12.6 | 17.3 | 13.2 | |
| ≥25% in census tract <high school diploma, % | 15.8 | 36.1 | 38.4 | <0.001 |
| ≥20% in census tract below poverty line, % | 12.7 | 26.7 | 19.2 | <0.001 |
| Public health insurance (Medicaid or Medicare), % | 12.4 | 10.2 | 4.9 | <0.001 |
| Median years (IQR) known HIV+ | 5.6 (1.4, 8.8) | 3.0 (0.3, 7.2) | 2.6 (0.2, 6.6) | <0.001 |
| Median CD4 T-cells/µL (IQR) | 234 (101, 377) | 186 (55, 325) | 212 (81, 355) | <0.001 |
| Median log10 HIV RNA c/mL (IQR) | 4.4 (3.5, 5.0) | 4.5 (3.6, 5.0) | 4.5 (3.6, 5.1) | 0.23 |
| Prior AIDS diagnosis, % | 58.0 | 59.6 | 58.3 | 0.66 |
| Prior use of antiretrovirals, % | 51.3 | 39.4 | 35.7 | <0.001 |
| PI-based ART regimen class, % | 65.6 | 59.2 | 61.3 | <0.001 |
| Hepatitis C co-infection, % | 9.6 | 14.8 | 7.6 | <0.001 |
| Depression diagnosis, % | 21.4 | 13.3 | 14.7 | <0.001 |
| Mean Charlson comorbidity index scoreb | 0.3 | 0.3 | 0.3 | 0.07 |
antiretroviral therapy, interquartile range
a Pearson’s chi-square test for categorical variables and Kruskal-Wallis for continuous variables.
b Modified Charlson comorbidity index which excludes HIV or AIDS-related outcomes.